| Primary |
| Endocarditis |
28.6% |
| Thrombosis Prophylaxis |
28.6% |
| Abdominal Pain Upper |
14.3% |
| Cardiac Failure |
14.3% |
| Drug Use For Unknown Indication |
14.3% |
|
|
| Secondary |
| Hypertension |
27.6% |
| Product Used For Unknown Indication |
22.7% |
| Drug Use For Unknown Indication |
18.2% |
| Thrombosis Prophylaxis |
4.2% |
| Hiv Infection |
3.4% |
| Depression |
2.5% |
| Rheumatoid Arthritis |
2.5% |
| Ear Infection |
2.0% |
| Cardiac Failure |
1.7% |
| Hypercholesterolaemia |
1.7% |
| Sleep Disorder |
1.7% |
| Atrial Fibrillation |
1.5% |
| Myocardial Infarction |
1.5% |
| Small Cell Lung Cancer Metastatic |
1.5% |
| Anxiety |
1.2% |
| Diabetes Mellitus |
1.2% |
| Dyslipidaemia |
1.2% |
| Hypothyroidism |
1.2% |
| Small Cell Lung Cancer |
1.2% |
| Type 2 Diabetes Mellitus |
1.2% |
|
| Syncope |
14.3% |
| Renal Failure Acute |
12.9% |
| Vomiting |
10.0% |
| Orthostatic Hypotension |
7.1% |
| Leukocytoclastic Vasculitis |
5.7% |
| Neuropathy Peripheral |
5.7% |
| Anaemia Haemolytic Autoimmune |
4.3% |
| Pneumonia Aspiration |
4.3% |
| Splenomegaly |
4.3% |
| Angioedema |
2.9% |
| Aortic Valve Disease |
2.9% |
| Dizziness |
2.9% |
| Haematoma |
2.9% |
| Nausea |
2.9% |
| Peripheral Motor Neuropathy |
2.9% |
| Peripheral Sensory Neuropathy |
2.9% |
| Pollakiuria |
2.9% |
| Polyneuropathy |
2.9% |
| Pruritus |
2.9% |
| Pulmonary Hypertension |
2.9% |
|
| Concomitant |
| Product Used For Unknown Indication |
23.1% |
| Drug Use For Unknown Indication |
22.0% |
| Hypertension |
20.1% |
| Type 2 Diabetes Mellitus |
3.7% |
| Renal Transplant |
3.6% |
| Cardiac Failure |
2.8% |
| Atrial Fibrillation |
2.7% |
| Ankylosing Spondylitis |
2.5% |
| Pneumonia |
2.0% |
| Prophylaxis |
2.0% |
| Myocardial Infarction |
1.9% |
| Bone Pain |
1.8% |
| Hypercholesterolaemia |
1.8% |
| Rheumatoid Arthritis |
1.8% |
| Multiple Myeloma |
1.7% |
| Pain |
1.7% |
| Diabetes Mellitus |
1.5% |
| Prophylaxis Against Transplant Rejection |
1.2% |
| Hepatitis C |
1.1% |
| Epilepsy |
1.0% |
|
| Renal Failure Acute |
15.2% |
| Thrombocytopenia |
9.1% |
| Renal Failure |
8.3% |
| Vomiting |
6.1% |
| Pyrexia |
5.3% |
| Acute Generalised Exanthematous Pustulosis |
4.5% |
| Rhabdomyolysis |
4.5% |
| Weight Increased |
4.5% |
| Hyperkalaemia |
3.8% |
| Myocardial Infarction |
3.8% |
| Pleural Effusion |
3.8% |
| Rectal Haemorrhage |
3.8% |
| Sepsis |
3.8% |
| Somnolence |
3.8% |
| Transaminases Increased |
3.8% |
| Visual Impairment |
3.8% |
| Deep Vein Thrombosis |
3.0% |
| Pancytopenia |
3.0% |
| Rash Maculo-papular |
3.0% |
| Toxic Skin Eruption |
3.0% |
|
| Interacting |
| Drug Use For Unknown Indication |
34.9% |
| Hypertension |
23.3% |
| Cardiomyopathy |
14.0% |
| Atrial Fibrillation |
11.6% |
| Hypothyroidism |
4.7% |
| Benign Prostatic Hyperplasia |
2.3% |
| Diabetes Mellitus |
2.3% |
| Gastrooesophageal Reflux Disease |
2.3% |
| Gout |
2.3% |
| Subileus |
2.3% |
|
| Orthostatic Hypotension |
27.3% |
| Syncope |
27.3% |
| Oedema Peripheral |
9.1% |
| Psoriasis |
9.1% |
| Renal Failure Acute |
9.1% |
| Tendon Rupture |
9.1% |
| Urinary Retention |
9.1% |
|
